Methods for quantifying adipose tissue insulin resistance in overweight/obese humans

International Journal of Obesity

Volumn 41, Issue 8, 2017, Pages 1288-1294

  Ter Horst, K W ^a   Van Galen, K A ^a   Gilijamse, P W ^a   Hartstra, A V ^a   De Groot, P F ^a   Van Der Valk, F M ^a   Ackermans, M T ^a   Nieuwdorp, M ^a,b,c   Romijn, J A ^a   Serlie, M J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FATTY ACID; GLYCEROL; INSULIN; TRACER; ANTIDIABETIC AGENT;

ADIPOSE TISSUE; ADULT; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOLYSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OBESITY; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; BODY MASS; COMPLICATION; DRUG EFFECTS; GLUCOSE CLAMP TECHNIQUE; METABOLIC SYNDROME X; METABOLISM; PATHOPHYSIOLOGY; REFERENCE VALUE; VALIDATION STUDY;

ADIPOSE TISSUE; ADULT; BODY MASS INDEX; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; LIPOLYSIS; MALE; METABOLIC SYNDROME; MIDDLE AGED; OBESITY; OVERWEIGHT; REFERENCE VALUES;

EID: 85026901010     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2017.110     Document Type: Article

References (50)

1. Cahill GF Jr. Starvation in man. N Engl J Med 1970; 282: 668-675.
2. Duncan RE, Ahmadian M, Jaworski K, Sarkadi-Nagy E, Sul HS. Regulation of lipolysis in adipocytes. Annu Rev Nutr 2007; 27: 79-101.
3. Sakharova AA, Horowitz JF, Surya S, Goldenberg N, Harber MP, Symons K et al. Role of growth hormone in regulating lipolysis, proteolysis, and hepatic glucose production during fasting. J Clin Endocrinol Metab 2008; 93: 2755-2759.
4. Lafontan M, Langin D. Lipolysis and lipid mobilization in human adipose tissue. Prog Lipid Res 2009; 48: 275-297.
5. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM. Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 1989; 83: 1168-1173.
6. Vatner DF, Majumdar SK, Kumashiro N, Petersen MC, Rahimi Y, Gattu AK et al. Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. Proc Natl Acad Sci USA 2015; 112: 1143-1148.
7. Bachmann OP, Dahl DB, Brechtel K, Machann J, Haap M, Maier T et al. Effects of intravenous and dietary lipid challenge on intramyocellular lipid content and the relation with insulin sensitivity in humans. Diabetes 2001; 50: 2579-2584.
8. Zhang L, Keung W, Samokhvalov V, Wang W, Lopaschuk GD. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochim Biophys Acta 2010; 1801: 1-22.
9. Magkos F, Mittendorfer B. Stable isotope-labeled tracers for the investigation of fatty acid and triglyceride metabolism in humans in vivo. Clin Lipidol 2009; 4: 215-230.
10. Klein S, Wolfe RR. The use of isotopic tracers in studying lipid metabolism in human subjects. Baillieres Clin Endocrinol Metab 1987; 1: 797-816.
11. Reshef L, Olswang Y, Cassuto H, Blum B, Croniger CM, Kalhan SC et al. Glycer-oneogenesis and the triglyceride/fatty acid cycle. J Biol Chem 2003; 278: 30413-30416.
12. Nurjhan N, Kennedy F, Consoli A, Martin C, Miles J, Gerich J. Quantification of the glycolytic origin of plasma glycerol: implications for the use of the rate of appearance of plasma glycerol as an index of lipolysis in vivo. Metabolism 1988; 37: 386-389.
13. Pyle L, Bergman BC, Nadeau KJ, Cree-Green M. Modeling changes in glucose and glycerol rates of appearance when true basal rates of appearance cannot be readily determined. Am J Physiol Endocrinol Metab 2016; 310: E323-E331.
14. Beylot M, Martin C, Beaufrere B, Riou JP, Mornex R. Determination of steady state and nonsteady-state glycerol kinetics in humans using deuterium-labeled tracer. J Lipid Res 1987; 28: 414-422.
15. Landau BR. Glycerol production and utilization measured using stable isotopes. Proc Nutr Soc 1999; 58: 973-978.
16. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
17. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999; 22: 1462-1470.
18. Gutch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab 2015; 19: 160-164.
19. Muniyappa R, Lee S, Chen H, Quon MJ. Current approaches for assessing insulin sensitivity and resistance in vivo: advantages, limitations, and appropriate usage. Am J Physiol Endocrinol Metab 2008; 294: E15-E26.
20. Singh B, Saxena A. Surrogate markers of insulin resistance: a review. World J Diabetes 2010; 1: 36-47.
21. Abdul-Ghani MA, Molina-Carrion M, Jani R, Jenkinson C, Defronzo RA. Adipocytes in subjects with impaired fasting glucose and impaired glucose tolerance are resistant to the anti-lipolytic effect of insulin. Acta Diabetol 2008; 45: 147-150.
22. Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S et al. Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic stea-tohepatitis. Hepatology 2009; 50: 1087-1093.
23. Fabbrini E, Magkos F, Conte C, Mittendorfer B, Patterson BW, Okunade AL et al. Validation of a novel index to assess insulin resistance of adipose tissue lipolytic activity in obese subjects. J Lipid Res 2012; 53: 321-324.
24. Van Pelt RE, Gozansky WS, Kohrt WM. A novel index of whole body antilipolytic insulin action. Obesity 2013; 21: E162-E165.
25. Sondergaard E, Jensen MD. Quantification of adipose tissue insulin sensitivity. J Investig Med 2016; 64: 989-991.
26. de Weijer BA, Aarts E, Janssen IM, Berends FJ, van de Laar A, Kaasjager K et al. Hepatic and peripheral insulin sensitivity do not improve 2 weeks after bariatric surgery. Obesity 2013; 21: 1143-1147.
27. ter Horst KW, Gilijamse PW, Ackermans MT, Soeters MR, Nieuwdorp M, Romijn JA et al. Impaired insulin action in the liver, but not in adipose tissue or muscle, is a distinct metabolic feature of impaired fasting glucose in obese humans. Metabolism 2016; 65: 757-763.
28. Ackermans MT, Pereira Arias AM, Bisschop PH, Endert E, Sauerwein HP, Romijn JA. The quantification of gluconeogenesis in healthy men by (2)H2O and [2-(13)C] glycerol yields different results: rates of gluconeogenesis in healthy men mea-sured with (2)H2O are higher than those measured with [2-(13)C]glycerol. J Clin Endocrinol Metab 2001; 86: 2220-2226.
29. Steele R, Wall JS, De Bodo RC, Altszuler N. Measurement of size and turnover rate of body glucose pool by the isotope dilution method. Am J Physiol 1956; 187: 15-24.
30. Teusink B, Voshol PJ, Dahlmans VE, Rensen PC, Pijl H, Romijn JA et al. Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake. Diabetes 2003; 52: 614-620.
31. Lomonaco R, Ortiz-Lopez C, Orsak B, Webb A, Hardies J, Darland C et al. Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease. Hepatology 2012; 55: 1389-1397.
32. Bonadonna RC, Groop LC, Zych K, Shank M, DeFronzo RA. Dose-dependent effect of insulin on plasma free fatty acid turnover and oxidation in humans. Am J Physiol 1990; 259: E736-E750.
33. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E et al. Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mel-litus. Evidence for multiple sites of insulin resistance. J Clin Invest 1989; 84: 205-213.
34. Perseghin G, Caumo A, Caloni M, Testolin G, Luzi L. Incorporation of the fasting plasma FFA concentration into QUICKI improves its association with insulin sensitivity in nonobese individuals. J Clin Endocrinol Metab 2001; 86: 4776-4781.
35. Rabasa-Lhoret R, Bastard JP, Jan V, Ducluzeau PH, Andreelli F, Guebre F et al. Modified quantitative insulin sensitivity check index is better correlated to hyperinsulinemic glucose clamp than other fasting-based index of insulin sensitivity in different insulin-resistant states. J Clin Endocrinol Metab 2003; 88: 4917-4923.
36. Bland JM, Altman DG. Measuring agreement in method comparison studies. Stat Methods Med Res 1999; 8: 135-160.
37. ter Horst KW, Gilijamse PW, Koopman KE, de Weijer BA, Brands M, Kootte RS et al. Insulin resistance in obesity can be reliably identified from fasting plasma insulin. Int J Obes 2015; 39: 1703-1709.
38. American Diabetes Association. Standards of medical care in diabetes-2015. Diabetes Care 2015; 38(Suppl 1): S1-S93.
39. Widjaja A, Morris RJ, Levy JC, Frayn KN, Manley SE, Turner RC et al. Within-and between-subject variation in commonly measured anthropometric and biochemical variables. Clin Chem 1999; 45: 561-566.
40. Magkos F, Patterson BW, Mittendorfer B. Reproducibility of stable isotope-labeled tracer measures of VLDL-triglyceride and VLDL-apolipoprotein B-100 kinetics. J Lipid Res 2007; 48: 1204-1211.
41. Thomsen C, Storm H, Christiansen C, Rasmussen OW, Larsen MK, Hermansen K et al. The day-to-day variation in insulin sensitivity in non-insulin-dependent diabetes mellitus patients assessed by the hyperinsulinemic-euglycemic clamp method. Metabolism 1997; 46: 374-376.
42. Moura FA, Carvalho LS, Cintra RM, Martins NV, Figueiredo VN, Quinaglia e Silva JC et al. Validation of surrogate indexes of insulin sensitivity in acute phase of myocardial infarction based on euglycemic-hyperinsulinemic clamp. Am J Physiol Endocrinol Metab 2014; 306: E399-E403.
43. Aloulou I, Brun JF, Mercier J. Evaluation of insulin sensitivity and glucose effectiveness during a standardized breakfast test: comparison with the minimal model analysis of an intravenous glucose tolerance test. Metabolism 2006; 55: 676-690.
44. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia 2010; 53: 1270-1287.
45. International Diabetes Federation. IDF Diabetes Atlas, 7th edn. International Diabetes Federation: Brussels, Belgium, 2015.
46. Hruby A, Hu FB. The epidemiology of obesity: a big picture. Pharmacoeconomics 2015; 33: 673-689.
47. Morigny P, Houssier M, Mouisel E, Langin D. Adipocyte lipolysis and insulin resistance. Biochimie 2015; 125: 259-266.
48. Vangipurapu J, Stancáková A, Pihlajamäki J, Kuulasmaa TM, Kuulasmaa T, Paananen J et al. Association of indices of liver and adipocyte insulin resistance with 19 confirmed susceptibility loci for type 2 diabetes in 6, 733 non-diabetic Finnish men. Diabetologia 2011; 54: 563-571.
49. Hershkop K, Besor O, Santoro N, Pierpont B, Caprio S, Weiss R. Adipose insulin resistance in obese adolescents across the spectrum of glucose tolerance. J Clin Endocrinol Metab 2016; 101: 2423-2431.
50. Santosa S, Jensen M. The sexual dimorphism of lipid kinetics in humans. Front Endocrinol 2013; 6: 103.